Leukocyte Surface Antigen CD47 Antibody Market – Immune Checkpoint Research Advancing Cancer Immunotherapy
Market Overview The leukocyte surface antigen CD47 antibody market is expanding as researchers target the "don't eat me" signal that cancer cells exploit to evade macrophage-mediated immune clearance. CD47-blocking antibodies aim to restore the innate immune system's ability to recognize and eliminate malignant cells, representing a complementary mechanism to T-cell-focused checkpoint...
0 Σχόλια 0 Μοιράστηκε 205 Views 0 Προεπισκόπηση